TY - JOUR
T1 - Risk for primary cephalosporin resistance in Gram-negative bacteremia
AU - John, Princy
AU - Shahbazian, Sona
AU - Lainhart, William D.
AU - Hayes, Justin
AU - Mochon, Brian
AU - Nix, David E.
N1 - Publisher Copyright:
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
PY - 2023/7/10
Y1 - 2023/7/10
N2 - Objective: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). Methods: This retrospective cohort study included 400 adults with Gram-negative bacteremia. The goal was to review 100 cases involving each species and approximately half resistant and half susceptible to first-line cephalosporins, ceftriaxone (EC or KP), or cefepime (ENC or PS). Logistic regression was used to identify factors predictive of resistance. Results: A total of 378 cases of Gram-negative bacteremia were included in the analysis. Multivariate analysis identified significant risk factors for resistance, including admission from a chronic care hospital, skilled nursing facility, or having a history of infection within the prior 6 months (OR 3.00, P <.0001), requirement for mechanical ventilation (OR 3.76, P <.0001), presence of hemiplegia (OR 3.54, P =.0304), and presence of a connective tissue disease (OR 3.77, P =.0291). Conclusions: Patients without the identified risk factors should be strongly considered for receiving ceftriaxone or cefepime rather than carbapenems and newer broad-spectrum agents.
AB - Objective: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). Methods: This retrospective cohort study included 400 adults with Gram-negative bacteremia. The goal was to review 100 cases involving each species and approximately half resistant and half susceptible to first-line cephalosporins, ceftriaxone (EC or KP), or cefepime (ENC or PS). Logistic regression was used to identify factors predictive of resistance. Results: A total of 378 cases of Gram-negative bacteremia were included in the analysis. Multivariate analysis identified significant risk factors for resistance, including admission from a chronic care hospital, skilled nursing facility, or having a history of infection within the prior 6 months (OR 3.00, P <.0001), requirement for mechanical ventilation (OR 3.76, P <.0001), presence of hemiplegia (OR 3.54, P =.0304), and presence of a connective tissue disease (OR 3.77, P =.0291). Conclusions: Patients without the identified risk factors should be strongly considered for receiving ceftriaxone or cefepime rather than carbapenems and newer broad-spectrum agents.
UR - http://www.scopus.com/inward/record.url?scp=85165328535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165328535&partnerID=8YFLogxK
U2 - 10.1017/ash.2023.202
DO - 10.1017/ash.2023.202
M3 - Article
AN - SCOPUS:85165328535
SN - 2732-494X
VL - 3
JO - Antimicrobial Stewardship and Healthcare Epidemiology
JF - Antimicrobial Stewardship and Healthcare Epidemiology
IS - 1
M1 - e121
ER -